Literature DB >> 34110734

Sexual Positioning Practices and Anal Human Papillomavirus Infection Among Young Men Who Have Sex with Men and Transgender Women-Chicago, Illinois, 2016-2018.

Ethan Morgan1, Elissa Meites2, Lauri E Markowitz2, Casey D Xavier Hall, Troy D Querec3, Elizabeth R Unger3, Richard A Crosby4, Michael E Newcomb, Brian Mustanski.   

Abstract

BACKGROUND: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States; men who have sex with men (MSM) have higher prevalence of infection and related disease compared with other men. We assessed whether differences in HPV acquisition exist among MSM according to their sexual positioning practices, as well as self-reported receipt of HPV vaccination.
METHODS: We enrolled young MSM and transgender women aged 18 to 26 years in Chicago, IL (N = 666). Participants self-reported their history of HPV vaccination and submitted self-collected anal swab specimens for type-specific HPV detection using an L1-consensus PCR assay. Multivariable logistic regression analyses were used to assess relationships between sexual positioning practices and detection of any HPV or quadrivalent HPV vaccine (4vHPV) types by vaccination status, defined as self-reported receipt of ≥1 HPV vaccine dose versus none.
RESULTS: Among 666 participants, 400 (60.1%) had any anal HPV, and 146 (21.9%) had a 4vHPV type. Among vaccinated participants, 18, 36, and 177 reported exclusively insertive, exclusively receptive, or both sexual positioning practices, respectively. Compared with participants reporting exclusively insertive anal sex, odds of any HPV were significantly higher among participants engaging exclusively in receptive anal sex (adjusted odds ratio [aOR], 5.90; 95% confidence interval [CI], 2.52-13.78), as well as those engaging in both (aOR, 3.32; 95% CI, 1.71-6.44). Vaccinated participants, compared with unvaccinated participants, had lower odds of 4vHPV-type HPV regardless of sexual positioning practices (aOR, 0.56; 95% CI, 0.34-0.92).
CONCLUSIONS: Adult men and transgender women who practice anal receptive sex have high prevalence of infection with any HPV. Routine vaccination of all adolescents is expected to reduce HPV-related disease incidence among adult MSM and transgender women as vaccinated cohorts age.
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34110734      PMCID: PMC8459672          DOI: 10.1097/OLQ.0000000000001433

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   3.868


  26 in total

1.  Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; E A Holly; M L Ralston; N Jay
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

Review 2.  Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.

Authors:  Dorothy A Machalek; Mary Poynten; Fengyi Jin; Christopher K Fairley; Annabelle Farnsworth; Suzanne M Garland; Richard J Hillman; Kathy Petoumenos; Jennifer Roberts; Sepehr N Tabrizi; David J Templeton; Andrew E Grulich
Journal:  Lancet Oncol       Date:  2012-03-23       Impact factor: 41.316

Review 3.  Sexual Positioning Among Men Who Have Sex With Men: A Narrative Review.

Authors:  Derek T Dangerfield; Laramie R Smith; Jeffery Williams; Jennifer Unger; Ricky Bluthenthal
Journal:  Arch Sex Behav       Date:  2016-05-13

4.  High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.

Authors:  J M Palefsky; E A Holly; M L Ralston; N Jay; J M Berry; T M Darragh
Journal:  AIDS       Date:  1998-03-26       Impact factor: 4.177

5.  Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; S Shiboski; A Moss
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-06

Review 6.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

Review 7.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

8.  Human Papillomavirus Vaccination Among Adults Aged 18-26, 2013-2018.

Authors:  Peter Boersma; Lindsey I Black
Journal:  NCHS Data Brief       Date:  2020-01

Review 9.  Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia.

Authors:  Nagayasu Egawa; Kiyofumi Egawa; Heather Griffin; John Doorbar
Journal:  Viruses       Date:  2015-07-16       Impact factor: 5.048

Review 10.  Anal intraepithelial neoplasia: A review of diagnosis and management.

Authors:  Joseph R Roberts; Lacey L Siekas; Andrew M Kaz
Journal:  World J Gastrointest Oncol       Date:  2017-02-15
View more
  3 in total

1.  Human papillomavirus vaccination coverage among young, gay, bisexual, and other men who have sex with men and transgender women - 3 U.S. cities, 2016-2018.

Authors:  Raiza Amiling; Rachel L Winer; Michael E Newcomb; Pamina M Gorbach; John Lin; Richard A Crosby; Brian Mustanski; Lauri E Markowitz; Elissa Meites
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 4.526

Review 2.  Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States.

Authors:  Elissa Meites; Timothy J Wilkin; Lauri E Markowitz
Journal:  Hum Vaccin Immunother       Date:  2022-03-16       Impact factor: 3.452

3.  Human Papillomavirus Prevalence and Vaccination Rates Among Users of Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Prevention.

Authors:  Paul Rotert; Christopher Wheldon; Jenn Kownack; Zoe Sullivan-Blum; Brendan Cokingtin; Karishma Khetani; Kavindu Ndeti; Kevin Skyes; Megha Ramaswamy
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.